POLG2
protein-codingDNA polymerase gamma 2, accessory subunit, the group of DNA polymerases
Gene summary
This gene encodes the processivity subunit of the mitochondrial DNA polymerase gamma. The encoded protein forms a heterotrimer containing one catalytic subunit and two processivity subunits. This protein enhances DNA binding and promotes processive DNA synthesis. Mutations in this gene result in autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions.[provided by RefSeq, Sep 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~19.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032799
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0012415
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0012415
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008003
Submitter: Orphanet
Inheritance Pattern: SD
Disease ID:MONDO:0018158
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0012415
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0030326
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032799
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to POLG2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_007215.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 107 | 110 | |||
| missense | 1 | 2 | 293 | 24 | 1 | 321 |
| nonsense | 6 | 8 | 4 | 18 | ||
| start loss | 3 | 3 | ||||
| frameshift | 14 | 2 | 9 | 25 | ||
| splice donor/acceptor (+/-2bp) | 8 | 3 | 11 | |||
| Total | 21 | 20 | 315 | 131 | 1 | 488 |
Highest pathogenic variant AF is 0.000046471454
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_009146.2 | 8 | MANE Select | |
| Ensembl | ENSP00000442563.2 | 8 | MANE Select | |
| Ensembl | ENSP00000464389.1 | 2 | Standard | |
| Ensembl | ENSP00000462071.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mitochondrial biogenesis
- Purine metabolism
- Pyrimidine metabolism
Biological Process
- in utero embryonic development
- DNA replication
- DNA-dependent DNA replication
- mitochondrial DNA replication
- DNA repair
Molecular Function
- DNA binding
- DNA-directed DNA polymerase activity
- protein binding
- identical protein binding
Cellular Component
- mitochondrial chromosome
- cytoplasm
- mitochondrion
- mitochondrial matrix
- mitochondrial nucleoid
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000539111
- Coding exons
- 8
- Length
- 19253
- Individuals with no LoFs
- 125668
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 80
- Defined
- 125748
- p
- 0.000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.347 | 270 | 254 | 1.06 | 0.0000122 | 3155 |
| Missense (PolyPhen) | 84 | 83.417 | 1.007 | 1038 | ||
| Synonymous | -0.345 | 103 | 98.6 | 1.04 | 0.00000478 | 947 |
| Loss of Function | 1.32 | 19 | 26.3 | 0.721 | 0.00000156 | 284 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00042 | 0.00042 | rare |
| European (Non-Finnish) | 0.00039 | 0.00038 | rare |
| South Asian | 0.00033 | 0.00033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Mitochondrial polymerase processivity subunit. Stimulates the polymerase and exonuclease activities, and increases the processivity of the enzyme. Binds to ss-DNA.;
- Disease
- DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131]: A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. {ECO:0000269|PubMed:16685652}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- LoFtool
- 0.383
- RVIS EVS
- 0.09
- RVIS percentile EVS
- 60.47
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.695
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |